FIGS, Inc. reported second quarter 2026 financial results for the period ended June 30, 2026, announcing net revenues of $196.6 million, a 28.8% year-over-year increase driven by higher order volume and average order value. The company achieved diluted earnings per share of $0.15 on net income of $28.4 million, with an adjusted EBITDA margin expanding to 18.6%. Concurrently, the Board authorized a $100.0 million increase to its existing share repurchase program, raising total authorization to $200.0 million and leaving approximately $119.2 million available for future buybacks as of August 6, 2026. The company also raised its full-year 2026 adjusted EBITDA margin outlook to 14.8%–15.0%. FIGS operates in the healthcare apparel industry, designing and selling direct-to-consumer scrubs and lifestyle products for medical professionals.

FIGS, Inc. held its 2026 annual meeting of stockholders on June 3, 2026. Stockholders elected three Class II directors, ratified the appointment of Ernst & Young LLP as the independent registered public accounting firm, and approved executive compensation on an advisory basis.